Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends.

[1]  Alessio Tovaglieri,et al.  An in silico Model of T Cell Infiltration Dynamics Based on an Advanced in vitro System to Enhance Preclinical Decision Making in Cancer Immunotherapy , 2022, Frontiers in Pharmacology.

[2]  Nora C. Toussaint,et al.  Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy , 2022, Cell genomics.

[3]  J. Oliveira,et al.  PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway , 2021, Frontiers in Cell and Developmental Biology.

[4]  Tamara Zietek,et al.  Drug Screening, Oral Bioavailability and Regulatory Aspects: A Need for Human Organoids , 2021, Pharmaceutics.

[5]  J. Merchant,et al.  Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids. , 2021, Cancer letters.

[6]  Michael G. Lerner,et al.  Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinoma , 2021, JCI insight.

[7]  L. Griffith,et al.  A microenvironment-inspired synthetic 3D model for pancreatic ductal adenocarcinoma organoids , 2021, Nature Materials.

[8]  R. Higuchi,et al.  Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers. , 2021, European journal of cancer.

[9]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[10]  W. Boesmans,et al.  The Emerging Role of Nerves and Glia in Colorectal Cancer , 2021, Cancers.

[11]  Jakob Nikolas Kather,et al.  Nerve fibers in the tumor microenvironment in neurotropic cancer—pancreatic cancer and cholangiocarcinoma , 2020, Oncogene.

[12]  Liangrong Shi,et al.  High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39+CD8+ T cells , 2020, Gut.

[13]  J. Mei,et al.  Does metformin improve the efficacy of standard epidermal growth factor receptor-tyrosine kinase inhibitor treatment for patients with advanced non-small-cell lung cancer? , 2020, Interactive cardiovascular and thoracic surgery.

[14]  Toshiro Sato,et al.  Wnt Signaling Shapes the Histological Variation in Diffuse Gastric Cancer. , 2020, Gastroenterology.

[15]  H. Kim,et al.  An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping , 2020, Cell.

[16]  Andrey Rzhetsky,et al.  Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids , 2020, Nature Communications.

[17]  D. Shi,et al.  Association Between Statin Use and Prognosis of Breast Cancer: A Meta-Analysis of Cohort Studies , 2020, Frontiers in Oncology.

[18]  M. Blok,et al.  Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer‐induced cachexia , 2020, Journal of cachexia, sarcopenia and muscle.

[19]  K. Tanabe,et al.  Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell , 2020, Oncogene.

[20]  Feng Zhang,et al.  IFlowPlate—A Customized 384‐Well Plate for the Culture of Perfusable Vascularized Colon Organoids , 2020, Advanced materials.

[21]  W. Liang,et al.  Aspirin and risk of different cancers: an umbrella meta-analysis , 2020, Annals of translational medicine.

[22]  D. Yong,et al.  Development of Colonic Organoids Containing Enteric Nerves or Blood Vessels from Human Embryonic Stem Cells , 2020, Cells.

[23]  H. Clevers,et al.  Homeostatic mini-intestines through scaffold-guided organoid morphogenesis , 2020, Nature.

[24]  Meng Li,et al.  Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance , 2020, Cellular and molecular gastroenterology and hepatology.

[25]  Antonio Moreno Ortiz,et al.  Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas , 2020, bioRxiv.

[26]  M. Tsao,et al.  Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor , 2020, Scientific Reports.

[27]  J. Netterville,et al.  Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids , 2020, iScience.

[28]  A. Krasnitz,et al.  Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes. , 2020, Cancer discovery.

[29]  J. Iovanna,et al.  Basal‐like and classical cells coexist in pancreatic cancer revealed by single‐cell analysis on biopsy‐derived pancreatic cancer organoids from the classical subtype , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  J. Cameron,et al.  Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer , 2020, Annals of surgery.

[31]  Francisco J. Sánchez-Rivera,et al.  SOAT1 promotes mevalonate pathway dependency in pancreatic cancer , 2020, The Journal of experimental medicine.

[32]  E. Nice,et al.  Overcoming cancer therapeutic bottleneck by drug repurposing , 2020, Signal Transduction and Targeted Therapy.

[33]  G. Ginsberg,et al.  Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer Organoids. , 2020, Current protocols in stem cell biology.

[34]  H. Clevers,et al.  Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses , 2020, EBioMedicine.

[35]  Joe T. Sharick,et al.  Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment , 2020, Frontiers in Oncology.

[36]  Shalini C. Pereira,et al.  Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy , 2020, Clinical Cancer Research.

[37]  L. Wood,et al.  Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome , 2020, Cancer Research.

[38]  H. Clevers,et al.  Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles , 2020, Gut.

[39]  Hongyang Wang,et al.  ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma , 2020, npj Precision Oncology.

[40]  D. Tuveson,et al.  Single-Pass vs 2-Pass Endoscopic Ultrasound-guided Fine-Needle Biopsy Sample Collection for Creation of Pancreatic Adenocarcinoma Organoids. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  Z. Li,et al.  Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids , 2020, Journal of Experimental & Clinical Cancer Research.

[42]  P. Frenette,et al.  Nerves in cancer , 2020, Nature Reviews Cancer.

[43]  A. Farmer,et al.  Gastrointestinal pain , 2020, Nature Reviews Disease Primers.

[44]  Kat S. Moore,et al.  Pancreatic cancer organoids recapitulate disease and allow personalized drug screening , 2019, Proceedings of the National Academy of Sciences.

[45]  M. Rao.  An increasingly complex view of intestinal motility , 2019, Nature Reviews Gastroenterology & Hepatology.

[46]  K. Tanabe,et al.  Annexin A10 is involved in the induction of pancreatic duodenal homeobox‑1 in gastric cancer tissue, cells and organoids. , 2019, Oncology reports.

[47]  Junjie Peng,et al.  Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer. , 2019, Cell stem cell.

[48]  E. Cuppen,et al.  Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients , 2019, Science Translational Medicine.

[49]  Jessica A Lavery,et al.  A rectal cancer organoid platform to study individual responses to chemoradiation , 2019, Nature Medicine.

[50]  Jake June-Koo Lee,et al.  A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling , 2019, Science Advances.

[51]  Sunghee E. Park,et al.  Organoids-on-a-chip , 2019, Science.

[52]  J. Iovanna,et al.  Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi) , 2019, Front. Oncol..

[53]  D. Aust,et al.  CFTR Expression Analysis for Subtyping of Human Pancreatic Cancer Organoids , 2019, Stem cells international.

[54]  R. L. Reis,et al.  Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine , 2019, Science Advances.

[55]  Y. Kanai,et al.  Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma. , 2019, Cell reports.

[56]  Sultan Gulce-Iz,et al.  Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment. , 2019, Gene.

[57]  J. Bader,et al.  Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity. , 2019, JCI insight.

[58]  Chiara Sabatti,et al.  Organoid Modeling of the Tumor Immune Microenvironment , 2018, Cell.

[59]  Hans Clevers,et al.  A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening. , 2018, Cell stem cell.

[60]  J. Qin,et al.  In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system. , 2018, Lab on a chip.

[61]  S. Meltzer,et al.  Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids. , 2018, Cancer letters.

[62]  M. Medvedovic,et al.  An Organoid-Based Preclinical Model of Human Gastric Cancer , 2018, Cellular and molecular gastroenterology and hepatology.

[63]  G. Ginsberg,et al.  Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells , 2018, Cellular and molecular gastroenterology and hepatology.

[64]  Hans Clevers,et al.  Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids , 2018, Cell.

[65]  Bon-Kyoung Koo,et al.  Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis , 2018, Cell.

[66]  Markus H. Heim,et al.  Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies , 2018, Cell reports.

[67]  Robert E Denroche,et al.  Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. , 2018, Cancer discovery.

[68]  Mechthild Krause,et al.  Human gastric cancer modelling using organoids , 2018, Gut.

[69]  Shelly Maman,et al.  A history of exploring cancer in context , 2018, Nature Reviews Cancer.

[70]  Andrea Pavesi,et al.  Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model , 2018, Front. Immunol..

[71]  Quy Xiao Xuan Lin,et al.  Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer. , 2018, Biomaterials.

[72]  J. Takagi,et al.  Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression. , 2018, Cell stem cell.

[73]  Andrea Sottoriva,et al.  Patient-derived organoids model treatment response of metastatic gastrointestinal cancers , 2018, Science.

[74]  Cheng Zhang,et al.  Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids , 2018, Scientific Reports.

[75]  Seok Chung,et al.  Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance , 2018, Journal of experimental & clinical cancer research : CR.

[76]  Bon-Kyoung Koo,et al.  Human Primary Liver Cancer -derived Organoid Cultures for disease modelling and drug screening , 2017, Nature Medicine.

[77]  C. Dive,et al.  Circulating tumor cells and CDX models as a tool for preclinical drug development. , 2017, Translational lung cancer research.

[78]  Andrea Pavesi,et al.  A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors. , 2017, JCI insight.

[79]  Noo Li Jeon,et al.  Biomimetic Model of Tumor Microenvironment on Microfluidic Platform , 2017, Advanced healthcare materials.

[80]  D. Tuveson,et al.  Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment. , 2017, Gastrointestinal endoscopy.

[81]  Daniel R. Berger,et al.  Cell diversity and network dynamics in photosensitive human brain organoids , 2017, Nature.

[82]  E. Martinelli,et al.  3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells , 2017, Scientific Reports.

[83]  Hans Clevers,et al.  Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer , 2017, The Journal of experimental medicine.

[84]  Ting Wu,et al.  Tumor microenvironment and therapeutic response. , 2017, Cancer letters.

[85]  Catherine L. Worth,et al.  Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors , 2017, Nature Communications.

[86]  Hans Clevers,et al.  Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer. , 2017, Cell reports.

[87]  Philippe Aubert,et al.  Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system , 2016, Nature Medicine.

[88]  Ji‐Hyun Lee,et al.  Co-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor Microenvironment , 2016, PloS one.

[89]  Hans Clevers,et al.  Modeling Development and Disease with Organoids , 2016, Cell.

[90]  Toshio Uraoka,et al.  A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis. , 2016, Cell stem cell.

[91]  A. Giaccia,et al.  The ever-expanding role of HIF in tumour and stromal biology , 2016, Nature Cell Biology.

[92]  Lisa M. Coussens,et al.  The Basis of Oncoimmunology , 2016, Cell.

[93]  Weidong Tian,et al.  Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined Approach , 2016, PloS one.

[94]  Hans Clevers,et al.  Organoid culture systems for prostate epithelial tissue and prostate cancer tissue , 2016, Nature Protocols.

[95]  Joshua M. Korn,et al.  High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response , 2015, Nature Medicine.

[96]  Hans Clevers,et al.  Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases , 2015, Proceedings of the National Academy of Sciences.

[97]  G. Bergers,et al.  Tumor angiogenesis, from foe to friend , 2015, Science.

[98]  Sara Reardon,et al.  ‘Organs-on-chips’ go mainstream , 2015, Nature.

[99]  Hayley E. Francies,et al.  Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.

[100]  Hans Clevers,et al.  Sequential cancer mutations in cultured human intestinal stem cells , 2015, Nature.

[101]  Joshua S. Kaminker,et al.  A resource for cell line authentication, annotation and quality control , 2015, Nature.

[102]  Florian Klemm,et al.  Microenvironmental regulation of therapeutic response in cancer. , 2015, Trends in cell biology.

[103]  Takanori Kanai,et al.  Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids , 2015, Nature Medicine.

[104]  M. Spector,et al.  Organoid Models of Human and Mouse Ductal Pancreatic Cancer , 2015, Cell.

[105]  S. Eccles,et al.  Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells , 2014, BMC Cancer.

[106]  Sohrab P. Shah,et al.  Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution , 2014, Nature.

[107]  Nancy R. Zhang,et al.  Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer , 2014, Genome Biology.

[108]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[109]  Juergen A. Knoblich,et al.  Organogenesis in a dish: Modeling development and disease using organoid technologies , 2014, Science.

[110]  Olivier Gevaert,et al.  Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture , 2014, Nature Medicine.

[111]  Manuel Hidalgo,et al.  Patient-derived xenograft models: an emerging platform for translational cancer research. , 2014, Cancer discovery.

[112]  Manuel Ochoa,et al.  Disease-on-a-chip: mimicry of tumor growth in mammary ducts. , 2014, Lab on a chip.

[113]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[114]  N. McGranahan,et al.  The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.

[115]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[116]  E. Young.  Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[117]  L. You,et al.  A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay , 2013, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[118]  Y. Sasai.  Next-generation regenerative medicine: organogenesis from stem cells in 3D culture. , 2013, Cell stem cell.

[119]  S. Toda,et al.  Establishment of a long-term three-dimensional primary culture of mouse glandular stomach epithelial cells within the stem cell niche. , 2013, Biochemical and biophysical research communications.

[120]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[121]  Aik Choon Tan,et al.  Patient-derived tumour xenografts as models for oncology drug development , 2012, Nature Reviews Clinical Oncology.

[122]  Hans Clevers,et al.  Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.

[123]  Holger Gerhardt,et al.  Basic and Therapeutic Aspects of Angiogenesis , 2011, Cell.

[124]  J. Cooper,et al.  Tumors on chips: oncology meets microfluidics. , 2010, Current opinion in chemical biology.

[125]  James A. Eddy,et al.  In silico models of cancer , 2010, Wiley interdisciplinary reviews. Systems biology and medicine.

[126]  Calvin J Kuo,et al.  Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche , 2009, Nature Medicine.

[127]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[128]  M. Olivotto,et al.  Environmental restrictions within tumor ecosystems select for a convergent, hypoxia-resistant phenotype of cancer stem cells , 2008, Cell cycle.

[129]  M. Gottesman,et al.  Comparing solid tumors with cell lines: implications for identifying drug resistance genes in cancer. , 2004, Molecular interventions.

[130]  T. Litman,et al.  A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins. , 2004, Cancer research.

[131]  Chunhui Xu,et al.  Feeder-free growth of undifferentiated human embryonic stem cells , 2001, Nature Biotechnology.

[132]  J. Maher,et al.  Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. , 1987, The Journal of clinical investigation.

[133]  L. Liotta,et al.  Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.

[134]  I. Ng,et al.  Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma , 2020, Hepatology.

[135]  Zhi Wei,et al.  Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. , 2018, Cancer discovery.

[136]  Ahmet Sacan,et al.  Applications and limitations of in silico models in drug discovery. , 2012, Methods in molecular biology.

[137]  Douglas B. Evans,et al.  Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice , 2009, Nature Protocols.

[138]  A. Stammati,et al.  The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics , 2005, Cell Biology and Toxicology.